CASP3 and neoplasm: Residual tumor tissues were collected at the end of the experiment and IHC studies revealed reduced expression of the proliferative marker Ki-67 (Fig. 4C and D) and increased expression of the cell death marker cleaved caspase-3 (Fig. 4E and F) in tumors treated with fimepinostat.